Morgan Stanley Maintains Equal-Weight on Organon, Raises Price Target to $27
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Terence Flynn has maintained an Equal-Weight rating on Organon (NYSE:OGN) and raised the price target from $25 to $27.
August 09, 2023 | 1:57 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley has maintained an Equal-Weight rating on Organon and raised the price target from $25 to $27, which could potentially lead to a positive market reaction.
The raised price target by Morgan Stanley indicates a positive outlook for Organon. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100